Article metrics
PDF
Other content recommended for you
- Considerations for vaccinating children against COVID-19
- SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
- COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities
- Children and adolescents in African countries should also be vaccinated for COVID-19
- Parents’ perspective on COVID-19 vaccine in children 6 months through 4 years: a cross-sectional study from Northwest Wisconsin
- Covid-19 vaccination in pregnancy
- Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England
- Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study
- COVID-19 vaccines: a look at the ethics of the clinical research involving children
- Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind